Oral drug delivery remains one of the most widely used and preferred administration routes, valued for its convenience, high patient compliance, and cost-effectiveness. However, its effectiveness is is often limited by several critical factors. These include the degradation of acid-labile active pharmaceutical ingredients (APIs) in the stomach’s harsh acidic environment, difficulties in achieving targeted release at optimal intestinal absorption sites, and the risk of gastrointestinal irritation caused by certain compounds.1
Addressing these challenges is essential to developing oral formulations that deliver consistent, effective, and well-tolerated therapeutic outcomes. This white paper explores how Lonza’s advanced polymer science and capsule manufacturing capabilities have led to a breakthrough in enteric protection.
Download the white paper to discover the innovation behind Capsugel® Enprotect® and how it is redefining oral drug delivery.
References
- 1. Kim J, De Jesus O. Medication Routes of Administration. Ncbi.nlm.nih.gov/books/NBK568677/ (accessed May 2025)